ROLE OF COMPLEMENT IN ENDOTOXIC SHOCK
ROLE OF COMPLEMENT IN ENDOTOXIC SHOCK
批准号:
3853060
负责人:
C NATANSON
金额:
$0.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Studies of normal humans given a sublethal dose of endotoxin have shown a
cardiopulmonary response similar to the response of humans with septic
shock. This normal human model has been used in controlled investigations
to elucidate the pathophysiology of septic shock (N Engl J Med
1989;321:280).
Septic shock is a highly lethal disease (50-50% mortality) despite optimal
antibiotic and cardiovascular supportive therapy. Mortality from septic
shock is caused by cardiovascular collapse or multiple organ system
failure. Sepsis is the most prevalent cause of death of patients in
intensive car units. Endotoxin, a component of the outer cell wall of
Gram-negative bacterial, is released into the circulation in patients with
septic shock and thought to be the major pathogenic toxin.
During sepsis host cells release mediators in response to bacterial toxins
(endotoxin). These mediators produce the characteristic cardiopulmonary
response of sepsis and septic shock. The complement system is a cascade of
host mediators that are activated during sepsis and may be beneficial or
harmful to the host. If complement produces, on balance, harmful effects
during sepsis, antagonists to complement are now available for humans and
would be considered for therapy for septic shock.
Brittany spaniels that are genetically deficient in the third component of
complement (C3) have been used in investigations of complement at Johns
Hopkins University. These dogs produce essentially no C3 (0.003% of normal
levels as determined by ELISA). They have normal levels of other
complement factors. C3 is required for activation of complement components
C5-C9 via classical and alternative pathways. Thus, investigation of
endotoxemia in these animals would clarify the pathophysiologic role of
complement.
This protocol proposes investigation of the effect of a sublethal endotoxin
infusion on C3 deficient Brittany spaniels. Because these animals are
difficult to breed and extremely scarce, there are a small number of these
valuable animals for investigation. In order to preserve these animals,
the dogs would be challenged with a sublethal dose of endotoxin that
produces cardiovascular profile similar to human septic shock.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
USE OF A SELECTIVE BRADYKININ ANTAGONIST IN A CANINE MODEL OF SEPTIC SHOCK
-
批准号:5201091
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:C NATANSON
-
依托单位:
NITRIC OXIDE SYNTHASE INHIBITORS IN VIVO TNF-INDUCED MYOCARDIAL DEPRESSION
-
批准号:3752179
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:C NATANSON
-
依托单位:
INVESTIGATIONS OF NEW THERAPIES IN SEPTIC SHOCK
-
批准号:3874266
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:C NATANSON
-
依托单位:
A COMPARISON OF STRAINS OF E. COLI TO PRODUCE SEPTIC SHOCK IN DOGS
-
批准号:3853021
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:C NATANSON
-
依托单位:
ROLE OF COMPLEMENT IN ENDOTOXIC SHOCK
-
批准号:3774439
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:C NATANSON
-
依托单位:
MYOCARDIAL METABOLISM IN A CANINE MODEL OF HUMAN BACTERIAL SEPSIS
-
批准号:3774436
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:C NATANSON
-
依托单位:
A COMPARISON OF TWO STRAINS OF E COLI TO PRODUCE SEPTIC SHOCK IN DOGS
-
批准号:6161407
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:C NATANSON
-
依托单位:
INVESTIGATIONS OF NEW THERAPIES IN SEPTIC SHOCK
-
批准号:3896256
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:C NATANSON
-
依托单位:
CONTROLLED TRIAL OF TYROSINE KINASE INHIBITORS IN CANINE MODEL OF SEPTIC SHOCK
-
批准号:2456661
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:C NATANSON
-
依托单位:
CARDIOPULMONARY PATHOPHYSIOLOGY IN CANINE SEPTIC SHOCK
-
批准号:3916459
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:C NATANSON
-
依托单位:
A COMPARISON OF TWO STRAINS OF E COLI TO PRODUCE SEPTIC SHOCK IN DOGS
-
批准号:5201066
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:C NATANSON
-
依托单位:
A COMPARISON OF STRAINS OF E. COLI TO PRODUCE SEPTIC SHOCK IN DOGS
-
批准号:3837914
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:C NATANSON
-
依托单位:
INVESTIGATIONS OF NEW THERAPIES IN SEPTIC SHOCK
-
批准号:3752157
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:C NATANSON
-
依托单位:
BACTERICIDAL-PERMEABILITY INCREASING PROTEIN IN A CANINE MODEL OF SEPTIC SHOCK
-
批准号:3752182
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:C NATANSON
-
依托单位:
ROLE OF COMPLEMENT IN ENDOTOXIC SHOCK
-
批准号:3837938
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:C NATANSON
-
依托单位:
INVESTIGATIONS OF NEW THERAPIES IN SEPTIC SHOCK
-
批准号:3853034
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:C NATANSON
-
依托单位:
CATHECOLAMINE THERAPY IN CANINE SEPTIC SHOCK
-
批准号:3916437
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:C NATANSON
-
依托单位:
ENDOGENOUS MEDIATORS IN THE PATHOPHYSIOLOGY OF CANINE SEPTIC SHOCK
-
批准号:3916436
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:C NATANSON
-
依托单位:
CANINE MODEL OF SEPTIC SHOCK
-
批准号:3963111
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:C NATANSON
-
依托单位:
RECONSTITUTED HIGH-DENSITY LIPOPROTEINS IN A CANINE MODEL OF SEPTIC SHOCK
-
批准号:5201090
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:C NATANSON
-
依托单位:
海外基金